Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 13351-13400 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04149470
Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)
PHASE4Active, not recruiting
90 participants
Started: Oct 7, 2020 · Completed: Aug 31, 2024
1 condition2 sponsors1 location
NCT04195399
A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
PHASE2Active, not recruiting
35 participants
Started: Oct 7, 2020 · Completed: Dec 31, 2025
3 conditions3 sponsors98 locations
NCT04440735
A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
125 participants
Started: Oct 7, 2020 · Completed: Sep 30, 2025
3 conditions1 sponsor7 locations
NCT04591431
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
PHASE2Active, not recruiting
400 participants
Started: Oct 7, 2020 · Completed: Jun 30, 2025
4 conditions1 sponsor37 locations
NCT04395222
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
PHASE2Active, not recruiting
21 participants
Started: Oct 7, 2020 · Completed: May 31, 2027
2 conditions1 sponsor1 location
NCT04009512
Endovascular Repair of Thoracoabdominal Aortic Aneurysms
NAActive, not recruiting
15 participants
Started: Oct 6, 2020 · Completed: Aug 26, 2026
1 condition4 sponsors1 location
NCT05002335
Clinical and Radiological Outcomes of Medacta Shoulder System (BE)
N/AActive, not recruiting
200 participants
Started: Oct 6, 2020 · Completed: Dec 31, 2027
7 conditions1 sponsor3 locations
NCT05699863
The MULTISITE Study
NAActive, not recruiting
90 participants
Started: Oct 6, 2020 · Completed: Jan 31, 2036
4 conditions1 sponsor1 location
NCT04278885
Lanadelumab in FXII-associated Cold Autoinflammatory Syndrome (FACAS)
PHASE2Active, not recruiting
4 participants
Started: Oct 5, 2020 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT04140162
Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy
PHASE2Active, not recruiting
57 participants
Started: Oct 5, 2020 · Completed: May 2, 2026
1 condition2 sponsors4 locations
NCT04458922
Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma
PHASE2Active, not recruiting
27 participants
Started: Oct 5, 2020 · Completed: Dec 13, 2025
6 conditions1 sponsor15 locations
NCT04536038
Framing Clinical Trial Enrollment for Patients With Peripheral Artery Disease
NAActive, not recruiting
1,200 participants
Started: Oct 5, 2020 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT04579237
Development and Evaluation of Techniques for Computer Aided Detection and Diagnosis From Existing Radiologic Images
N/AActive, not recruiting
144,625 participants
Started: Oct 5, 2020 · Completed: Jun 30, 2030
1 condition1 sponsor1 location
NCT04576377
Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures
PHASE4Active, not recruiting
977 participants
Started: Oct 5, 2020 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT05465057
"HIIT Med Kiloene."
NAActive, not recruiting
172 participants
Started: Oct 5, 2020 · Completed: Nov 30, 2024
2 conditions6 sponsors1 location
NCT03654053
Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis
PHASE3Active, not recruiting
142 participants
Started: Oct 2, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor11 locations
NCT04262141
IMG-7289 in Patients with Essential Thrombocythemia (ET) or Polycythemia Vera (PV)
PHASE2Active, not recruiting
4 participants
Started: Oct 2, 2020 · Completed: Oct 31, 2026
2 conditions2 sponsors1 location
NCT04682964
Bacteriophage Therapy in Tonsillitis
PHASE3Active, not recruiting
128 participants
Started: Oct 2, 2020 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT04585035
Study to Evaluate D-1553 in Subjects With Solid Tumors
PHASE1/PHASE2Active, not recruiting
180 participants
Started: Oct 2, 2020 · Completed: Dec 31, 2025
3 conditions2 sponsors25 locations
NCT04293393
Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients
PHASE2Active, not recruiting
200 participants
Started: Oct 2, 2020 · Completed: Feb 28, 2033
1 condition2 sponsors28 locations
NCT04590963
Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer
PHASE3Active, not recruiting
370 participants
Started: Oct 2, 2020 · Completed: Sep 24, 2025
1 condition2 sponsors127 locations
NCT04589468
Researching the Effect of Exercise on Cancer
NAActive, not recruiting
33 participants
Started: Oct 2, 2020 · Completed: Oct 2, 2025
12 conditions1 sponsor8 locations
NCT03947957
Microbial Biomarkers of EArly Pseudomonas Aeruginosa Colonization in CHildren With Cystic Fibrosis
NAActive, not recruiting
70 participants
Started: Oct 2, 2020 · Completed: Jul 31, 2026
1 condition1 sponsor11 locations
NCT04589546
Does High-dose Vitamin B3 Supplementation Prevent Major Adverse Kidney Events During Septic Shock?
PHASE3Active, not recruiting
310 participants
Started: Oct 1, 2020 · Completed: Sep 30, 2025
4 conditions15 sponsors1 location
NCT04568993
The TriggerHappy Trial
NAActive, not recruiting
100 participants
Started: Oct 1, 2020 · Completed: Jul 1, 2026
3 conditions1 sponsor1 location
NCT04093349
A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)
PHASE1/PHASE2Active, not recruiting
4 participants
Started: Oct 1, 2020 · Completed: Apr 30, 2032
7 conditions1 sponsor29 locations
NCT04726800
Circulating Tumour DNA (ctDNA) as a Prognostic and Predictive Marker in Colorectal Cancer - a Pilot Study
N/AActive, not recruiting
300 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor8 locations
NCT04562337
SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC
PHASE2Active, not recruiting
67 participants
Started: Oct 1, 2020 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT04627480
Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial
PHASE4Active, not recruiting
200 participants
Started: Oct 1, 2020 · Completed: Feb 21, 2021
3 conditions2 sponsors1 location
NCT06548308
Comparison of Corneal Incision Versus Toric Intraocular Lens Techniques Used in Cataract Surgery
NAActive, not recruiting
368 participants
Started: Oct 1, 2020 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT04148560
Free-living Validation of the RFPM in Adolescents
NAActive, not recruiting
29 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06172868
Home Ventilatory Support in Children
N/AActive, not recruiting
94 participants
Started: Oct 1, 2020 · Completed: Dec 1, 2027
1 condition1 sponsor1 location
NCT04550689
Comparison of Dimensional Changes After Tooth Extractions Between Xenograft and Allograft
NAActive, not recruiting
12 participants
Started: Oct 1, 2020 · Completed: Jun 30, 2024
1 condition2 sponsors1 location
NCT05915065
VR to Evaluate Phantom Limb Pain
NAActive, not recruiting
48 participants
Started: Oct 1, 2020 · Completed: Sep 30, 2025
15 conditions2 sponsors1 location
NCT04909294
Evaluation of the Efficacy and the Safety of a Stereotaxic Prostatic Radiotherapy Delivered With Linac MRI, in Patients With Prostate Adenocarcinoma
NAActive, not recruiting
68 participants
Started: Oct 1, 2020 · Completed: Oct 1, 2030
1 condition1 sponsor1 location
NCT04590508
A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease
PHASE2Active, not recruiting
20 participants
Started: Oct 1, 2020 · Completed: Jul 30, 2025
1 condition3 sponsors1 location
NCT03935282
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors
NAActive, not recruiting
600 participants
Started: Oct 1, 2020 · Completed: Oct 31, 2025
6 conditions4 sponsors12 locations
NCT05138055
The NOrwegian Tick-borne Encephalitis Study
N/AActive, not recruiting
153 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2027
1 condition5 sponsors3 locations
NCT04442048
Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure
PHASE3Active, not recruiting
195 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2025
2 conditions7 sponsors8 locations
NCT04521686
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
PHASE1Active, not recruiting
200 participants
Started: Oct 1, 2020 · Completed: May 31, 2026
4 conditions1 sponsor33 locations
NCT02971046
Glutathione (GSH) Synthesis in Healthy School-aged Children and Healthy Young and Old Adults
NAActive, not recruiting
55 participants
Started: Oct 1, 2020 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT04416412
ICG Fluorescence Imaging in Open Fracture Trauma Patients
N/AActive, not recruiting
180 participants
Started: Oct 1, 2020 · Completed: Jan 31, 2026
1 condition6 sponsors4 locations
NCT03756480
Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance
N/AActive, not recruiting
135 participants
Started: Oct 1, 2020 · Completed: Oct 1, 2026
2 conditions3 sponsors3 locations
NCT04541797
Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics with Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM)
NAActive, not recruiting
160 participants
Started: Oct 1, 2020 · Completed: Feb 28, 2025
2 conditions1 sponsor1 location
NCT06794346
Sexual Effects of Transdermal or Vaginal Testosterone
PHASE2Active, not recruiting
132 participants
Started: Oct 1, 2020 · Completed: Nov 1, 2025
4 conditions1 sponsor1 location
NCT04515238
Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL
PHASE2Active, not recruiting
42 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2026
1 condition1 sponsor11 locations
NCT04484623
Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma
PHASE3Active, not recruiting
302 participants
Started: Oct 1, 2020 · Completed: Oct 25, 2029
1 condition1 sponsor119 locations
NCT04549428
Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC
PHASE2Active, not recruiting
12 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2024
1 condition4 sponsors3 locations
NCT04946409
Burden of Disease and Functional Impairment in XLH
N/AActive, not recruiting
60 participants
Started: Oct 1, 2020 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT04133792
Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC)
PHASE3Active, not recruiting
571 participants
Started: Oct 1, 2020 · Completed: Mar 31, 2030
1 condition1 sponsor12 locations